Isabela Domínguez Fernández

Isabela Domínguez Fernández

Auto-generated profile, based on publicly available information

Isabela Domínguez Fernández

Universidad de Oriente, Santiago de Cuba, Cuba

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024 in Orange Journal
Verified
Journal Article
Open access
CBClara Azalea Azalea Berenguer Berenguer
Clara Azalea Azalea Berenguer Berenguer
IFIsabela Domínguez Fernández
Isabela Domínguez Fernández
FRFélix Jesús Labañino Roldo
Félix Jesús Labañino Roldo
SBSilvia del Carmén Molina Bertrán
Silvia del Carmén Molina Bertrán
Annarli Olivia Rodriguez FereiroAnnarli Olivia Rodriguez Fereiro
Annarli Olivia Rodriguez Fereiro
Anticonvulsants are crucial for treating neurological diseases, necessitating close pharmacovigilance due to their potential risks. For this reason, a prospective descriptive study was conducted to characterize drug-related adverse reactions associated with the use of carbamazepine in the health area of the "Ramon Lopez Peña" Polyclinic, covering the period from July to December 2022. The sample consisted of 35 patients, characterized based on demographic, clinical, and pharmacotherapeutic variables. The detected drug-related adverse events were classified according to causality, severity, and frequency of occurrence. The results showed that the age group of 40-75 years (45.7%) predominated, along with female gender, mixed ethnicity, pre-university education level, and 54.2% did not have any unhealthy habits. The most common diagnosis was epilepsy (68.4%) and among the associated diseases, hypertension was prevalent. The most consumed medications were captopril, hydrochlorothiazide, paracetamol, and metamizole (dipirona). Drug interactions were detected, and 73 adverse reactions occurred, with the nervous system being the most affected at 56.0%. Possible adverse reactions (42.5%), frequent (49.4%), and mild (58.9%) predominated. This study underscores the importance of continuous and effective monitoring in pharmacovigilance to enhance patient safety under carbamazepine treatment, thereby promoting a more rational use of this medication.